SHR-A1921 Combined With Bevacizumab in Triple-negative Breast Cancer With Brain Metastases

Conditions: TNBC; Brain Metastasis Interventions: Drug: SHR-A1921 + Bevacizumab Sponsors: Fudan University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials